Kurma Partners focuses on European healthcare and biotechnology, investing from company creation through capital expansion. They leverage strong academic partnerships to transform disruptive scientific discoveries into medicines, diagnostics, and medical devices that address high‑unmet medical needs.
Industries
Industry breakdown
Top industries in the portfolio
Geography
Geographic scope
Europe
Geography breakdown
Darker regions = more portfolio companies
Top 5 countries
France
45.9%Switzerland
9.8%Netherlands
8.2%Belgium
3.3%Germany
3.3%Other
16.4%Countries with a higher share of the portfolio are shaded darker on the map.
Stages
Stage indicator
Stage agnostic
Stage breakdown
Portfolio by stage
Portfolio vintage
Companies by founded year
Fund details
Funds
Kurma Biofund IV
Vintage 2024 • $173.8M
Kurma Growth Opportunities
Vintage 2024 • $183.7M
Kurma Diagnostics II
Vintage 2021 • $91.3M
Kurma Biofund III
Vintage 2018 • $176.0M
Paris Saclay Seed Fund
Vintage 2017 • $58.3M
Kurma Diagnostics
Vintage 2015 • $38.5M
Kurma Biofund II
Vintage 2013 • $60.5M
Kurma Biofund I
Vintage 2009 • $56.1M